Atavistik Bio: Funding, Investors & Team (Oct 2026)
Atavistik Bio is a biotechnology company that specializes in the discovery and development of precision allosteric small molecules aimed at treating metabolic diseases and cancer. The company aims to revolutionize therapeutic approaches by focusing on selective allosteric therapeutics, which can potentially transform treatment options for serious diseases.
Atavistik Bio has raised $160M across 2 funding rounds on record, the most recent a Series B of $40.0M announced in Mar 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Atavistik Bio Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Atavistik Bio Funding Rounds
Atavistik Bio raised $120M in a Series B announced in Dec 2025.
3 months later, a Series B of $40.0M was announced in Mar 2026.
Atavistik Bio Founders and Leadership Team
Contact details for the Atavistik Bio team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Atavistik Bio Funding Compared to Other Biotechnology Startups
Atavistik Bio's latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Atavistik Bio in Biotechnology and Cambridge
Companies Similar to Atavistik Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Atavistik Bio Funding FAQs
What does Atavistik Bio do?
Atavistik Bio is a biotechnology company that specializes in the discovery and development of precision allosteric small molecules aimed at treating metabolic diseases and cancer. The company aims to revolutionize therapeutic approaches by focusing on selective allosteric therapeutics, which can potentially transform treatment options for serious diseases.
How much funding has Atavistik Bio raised?
Atavistik Bio has raised $160M across 2 rounds on record. The most recent is a Series B of $40.0M announced in Mar 2026.
When did Atavistik Bio last raise funding?
Atavistik Bio's most recent funding round on record is a Series B of $40.0M, announced in Mar 2026.
Who founded Atavistik Bio?
FundedIQ lists Bryan Stuart (Founder), Jared Rutter (Founder) at Atavistik Bio.
Where is Atavistik Bio headquartered?
Atavistik Bio is based in Cambridge, Massachusetts, United States.
How many employees does Atavistik Bio have?
Atavistik Bio is in the 11-50 employee band.
How does Atavistik Bio's funding compare to other Biotechnology startups?
Atavistik Bio's latest round of $40.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Atavistik Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Atavistik Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.